ERIN SCOTT: Open Payments
NPI 1144599929 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 18 payments from 10 companies in 2025. Trend: 2023 $201 · 2024 $352 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Corcept Therapeutics | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Abbott Laboratories | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: Rybelsus, BREZTRI, Korlym, Veozah, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, TRELEGY ELLIPTA, KRYSTEXXA.
Industry payments across SC — which companies pay providers there.
